Robert Blanks - 16 Jan 2024 Form 4 Insider Report for ARDELYX, INC. (ARDX)

Role
Chief Regulatory and Quality Affairs Officer
Signature
/s/ Elizabeth Grammer, Attorney-in-Fact for Robert Blanks
Issuer symbol
ARDX
Transactions as of
16 Jan 2024
Transactions value $
$0
Form type
4
Filing time
18 Jan 2024, 16:31:53
Previous filing
22 Nov 2023
Next filing
22 Feb 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ARDX Common Stock Award $0 +113K +43.29% $0.00 373K 16 Jan 2024 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ARDX Stock Option (Right to Buy) Award $0 +145K $0.00 145K 16 Jan 2024 Common Stock 145K $8.78 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Restricted stock units ("RSUs"). The Reporting Person is entitled to receive one (1) shares of Common Stock for each one (1) RSU upon the vesting thereof.
F2 The option becomes exercisable as it vests and the shares subject to the option vest in 48 successive, equal monthly installments on each monthly anniversary of January 16, 2024, subject to the Reporting Person's continued employment or service relationship with the Issuer on each such vesting date.

Remarks:

Chief Regulatory and Quality Affairs Officer